The Global Plan to Stop TB
The Global Plan to Stop TB: 2006–2015 is a 10-year business plan developed by the Stop TB Partnership to outline the activities necessary and resources needed to achieve the Millennium Development Goal target for TB by 2015 and eliminate TB as a global public health problem by 2050. Produced with assistance from over 150 experts in the TB community and endorsed by the World Health Organization, the World Bank, and the United States Agency for International Development (USAID), the plan was created in order to: (1) provide a roadmap for engaging countries in the activities needed to implement the WHO Stop TB Strategy, and (2) act as a living document that adapts to the ever-changing global TB situation; accomplished through specialized working groups that modify and update the Global Plan as necessary.
Funding the Global Plan
-
The Global Plan estimates the ten-year cost of TB control to be US$56 billion, which includes:
-
US$47 billion for expansion of detection and treatment interventions
-
US$9 billion in research and development for new tools — diagnostics, drugs and a vaccine.
- A shared investment of approximately US$5-6 billion per year by affected countries and donors; a figure which includes both implementation of current interventions and research and development for vaccines, diagnostics, and drugs.
-
-
As of 2006, only 45 percent of the total cost is likely to be available, resulting in a funding gap of at least US$30.8 billion.
-
In addition to these calculations, another $2.15 billion per year is needed to address the recent onslaught of drug-resistant TB and research needs.
Planned Achievements
If fully funded and implemented over the next ten years, the plan will achieve the following:
-
14 million lives saved.
-
50 million people treated, including 1.6 million patients with multidrug-resistant TB (MDR-TB) and three million patients co-infected with TB and HIV will be enrolled on antiretroviral therapy.
-
The first new TB drug in over 40 years.
-
Point of care diagnostics that allow for the rapid, sensitive and inexpensive detection of TB.
-
A new, safe, effective and affordable vaccine.
Africa's Need
Africa has the highest rates of TB in the world, as well as the largest gaps in available and pledged funding. For this reason, the Global Plan places special emphasis on the need to fully fund TB control in Africa. The funding gap for TB control in developing countries is at least $15 billion over the next decade, $11 billion of which is Africa’s gap alone. According to the Global Plan, Africa requires $19.4 billion for TB control through 2015. Africa's TB pandemic is so severe that the region's Ministers of Health, in concert with WHO, declared TB to be a continent-wide emergency.
For more information, visit the Global Plan website.
